The histone deacetylase inhibitor, trichostatin A, reactivates the developmentally silenced γ globin expression in somatic cell hybrids and induces γ gene expression in adult BFUe cultures-Reference-Cited by-同舟云学术

The histone deacetylase inhibitor, trichostatin A, reactivates the developmentally silenced γ globin expression in somatic cell hybrids and induces γ gene expression in adult BFUe cultures

Published:2003-05 Issue:3 Volume:30 Page:254-257
ISSN:1079-9796
Container-title:Blood Cells, Molecules, and Diseases
language:en
Short-container-title:Blood Cells, Molecules, and Diseases

Author:

Swank Richard A,Skarpidi Eva,Papayannopoulou Thalia,Stamatoyannopoulos George

Publisher

Elsevier BV

Subject

Cell Biology,Hematology,Molecular Biology,Molecular Medicine

Reference15 articles.

1. Butyrate infusions in the ovine fetus delay the biologic clock for globin gene switching;Perrine;Proc. Natl. Acad. Sci. USA,1988

2. α-Amino-N-butyric acid stimulates fetal hemoglobin in the adult;Constantoulakis;Blood,1988

3. On the induction of fetal hemoglobin by butyrates: in vivo and in vitro studies with sodium butyrate and comparison of combination treatments with 5-AzaC and AraC;Constantoulakis;Blood,1989

4. Sodium butyrate enhances fetal globin gene expression in erythroid progenitors of patients with Hb SS and beta thalassemia;Perrine;Blood,1989

5. Sustained induction of fetal hemoglobin by pulse butyrate therapy in sickle cell disease;Atweh;Blood,1999

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Reactivation of Fetal Hemoglobin for Treating β-Thalassemia and Sickle Cell Disease;Advances in Experimental Medicine and Biology;2017

2. Valproic acid promotes neuronal differentiation by induction of neuroprogenitors in human bone-marrow mesenchymal stromal cells;Neuroscience Letters;2013-10

3. β-Thalassemia Due to Intronic LINE-1 Insertion in theβ-GlobinGene (HBB): Molecular Mechanisms Underlying Reduced Transcript Levels of theβ-GlobinL1Allele;Human Mutation;2013-08-13

4. Chemical genetic strategy identifies histone deacetylase 1 (HDAC1) and HDAC2 as therapeutic targets in sickle cell disease;Proceedings of the National Academy of Sciences;2010-06-28

5. Non-Cancer Uses of Histone Deacetylase Inhibitors: Effects on Infectious Diseases and β-Hemoglobinopathies+;Current Topics in Medicinal Chemistry;2009-02-01